Description
Class C07J : STEROIDS
Subclass 3/00: Normal steroids containing carbon, hydrogen, halogen, or oxygen, substituted in position 17 beta by one carbon atom
C07J 3/00
Sub-Class
Stats
- 72 US PATENTS IN FORCE
- 5 US APPLICATIONS PENDING
- 33 Total Patent Owners
- 420 TOTAL INVENTORS
Recent Patents
| Patent # | Title | Filing Date | Issue Date | Patent Owner |
|---|---|---|---|---|
| 12201640 | 19-nor C3,3-disubstituted C21-n-pyrazolyl steroids and methods of use thereof | Dec 23, 21 | Jan 21, 25 | SAGE THERAPEUTICS, INC. |
| 12129275 | Neuroactive steroids, compositions, and uses thereof | Mar 29, 22 | Oct 29, 24 | SAGE THERAPEUTICS, INC. |
| 12065463 | Compositions and methods for treating CNS disorders | Oct 24, 22 | Aug 20, 24 | SAGE THERAPEUTICS, INC. |
| 11945836 | Compositions and methods for treating CNS disorders | Oct 04, 22 | Apr 02, 24 | SAGE THERAPEUTICS, INC. |
| 11814408 | Preparations of hydrophobic therapeutic agents, methods of manufacture and use thereof | Feb 17, 21 | Nov 14, 23 | NICOX OPHTHALMICS, INC |
| 11583586 | Methods to induce targeted protein degradation through bifunctional molecules | Sep 28, 20 | Feb 21, 23 | Dana Farber Cancer Institute Inc. |
| 11542298 | Hydroxysteroid compounds, their intermediates, process of preparation, composition and uses thereof | Mar 03, 20 | Jan 03, 23 | EPIRIUM BIO INC. |
| 11542297 | Compositions and methods for treating CNS disorders | Mar 15, 22 | Jan 03, 23 | SAGE THERAPEUTICS, INC. |
| 11530237 | Compositions and methods for treating CNS disorders | Jan 21, 20 | Dec 20, 22 | SAGE THERAPEUTICS, INC. |
| 11382921 | Use of compounds in preparation of a medicament for treatment of hemorrhagic stroke | Dec 28, 18 | Jul 12, 22 | GUANGZHOU CELLPROTEK PHARMACEUTICAL CO., LTD |
| 11344563 | 19-nor C3, 3-disubstituted C21-C-bound heteroaryl steroids and methods of use thereof | Jul 10, 19 | May 31, 22 | SAGE THERAPEUTICS, INC. |
| 11261211 | 19-NOR neuroactive steroids and methods of use thereof | Jun 13, 19 | Mar 01, 22 | SAGE THERAPEUTICS, INC. |
| 11241446 | 19-nor C3, 3-disubstituted C21-N-pyrazolyl steroids and methods of use thereof | May 31, 19 | Feb 08, 22 | SAGE THERAPEUTICS, INC. |
| 11147877 | Compositions and methods for treating CNS disorders | Aug 20, 19 | Oct 19, 21 | SAGE THERAPEUTICS, INC. |
| 10954263 | Preparations of hydrophobic therapeutic agents, methods of manufacture and use thereof | Nov 28, 18 | Mar 23, 21 | NICOX OPHTHALMICS, INC |
| 10849980 | Methods to induce targeted protein degradation through bifunctional molecules | Jan 31, 19 | Dec 01, 20 | Dana Farber Cancer Institute Inc. |
| 10774108 | Compositions and methods for treating CNS disorders | Nov 27, 15 | Sep 15, 20 | SAGE THERAPEUTICS, INC. |
| 10759828 | Neuroactive steroids, compositions, and uses thereof | Aug 28, 18 | Sep 01, 20 | SAGE THERAPEUTICS, INC. |
| 10618933 | Hydroxysteroid compounds, their intermediates, process of preparation, composition and uses thereof | Jul 23, 15 | Apr 14, 20 | EPIRIUM BIO INC. |
| 10577390 | Compositions and methods for treating CNS disorders | Oct 16, 15 | Mar 03, 20 | SAGE THERAPEUTICS, INC. |
Recent Publications
| Publication # | Title | Filing Date | Pub Date | Patent Owner |
|---|---|---|---|---|
| 2025/0042,934 | COMPOSITIONS AND METHODS FOR TREATING CNS DISORDERS | Feb 20, 24 | Feb 06, 25 | Not available |
| 2024/0368,213 | COMPOSITIONS AND METHODS FOR TREATING CNS DISORDERS | Jun 12, 24 | Nov 07, 24 | Not available |
| 2018/0362,573 | NEUROACTIVE STEROIDS, COMPOSITIONS, AND USES THEREOF | Aug 28, 18 | Dec 20, 18 | Not available |
| 2015/0376,225 | NOVEL COMPOUNDS OF 11BETA-HYDROXY-STEROIDS FOR USE IN MITOCHONDRIA BIOGENESIS AND DISEASES ASSOCIATED WITH MITOCHONDRIAL DYSFUNCTION OR DEPLETION | Jan 23, 14 | Dec 31, 15 | SPHAERA PHARMA PVT. LTD. |
| 2015/0158,903 | NEUROACTIVE STEROIDS, COMPOSITIONS, AND USES THEREOF | Sep 07, 12 | Jun 11, 15 | SAGE THERAPEUTICS, INC. |
Top Owners in This Subclass
| Upgrade to the Professional Level to view Top Owners for this Subclass.Learn More |
|---|
Patents Issued To Date - By Filing Year
Average Time to Issuance
- 33 Months (last 2 years Issuances)
- 33 Months (last 5 years Issuances)